belantamab mafodotin
gsk
['belantamab,mafodotin', 'belantamab']
watch the interview with dr. kastritis explaining the results he presented yesterday at #eha2023 about the clinical trial emn 27, which tests belantamab mafodotin in relapsed or refractory #alamyloidosis patients. 
A network of highly efficient, effective and sustainable myeloma and AL amyloidosis patient organisations across Europe